DELCATH SYSTEMS INC (DCTH) Stock Fundamental Analysis
NASDAQ:DCTH - Nasdaq - US24661P8077 - Common Stock - Currency: USD
DCTH gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 187 industry peers in the Health Care Equipment & Supplies industry. DCTH is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. DCTH is growing strongly while it is still valued neutral. This is a good combination!
1. Profitability
1.1 Basic Checks
DCTH had positive earnings in the past year.
In the past year DCTH had a positive cash flow from operations.
DCTH had negative earnings in each of the past 5 years.
In the past 5 years DCTH always reported negative operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 1.91%, DCTH is in the better half of the industry, outperforming 74.33% of the companies in the same industry.
DCTH has a better Return On Equity (2.13%) than 74.87% of its industry peers.
DCTH's Return On Invested Capital of 3.72% is fine compared to the rest of the industry. DCTH outperforms 73.26% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.91% | ||
| ROE | 2.13% | ||
| ROIC | 3.72% |
ROA(3y)-120.78%
ROA(5y)-101.94%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
DCTH has a Profit Margin of 3.18%. This is in the better half of the industry: DCTH outperforms 73.80% of its industry peers.
With a decent Operating Margin value of 7.14%, DCTH is doing good in the industry, outperforming 74.33% of the companies in the same industry.
With an excellent Gross Margin value of 85.86%, DCTH belongs to the best of the industry, outperforming 96.79% of the companies in the same industry.
DCTH's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.14% | ||
| PM (TTM) | 3.18% | ||
| GM | 85.86% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.01%
GM growth 5Y8.9%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DCTH is destroying value.
DCTH has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, DCTH has more shares outstanding
There is no outstanding debt for DCTH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
DCTH has an Altman-Z score of 13.95. This indicates that DCTH is financially healthy and has little risk of bankruptcy at the moment.
DCTH has a Altman-Z score of 13.95. This is amongst the best in the industry. DCTH outperforms 93.05% of its industry peers.
There is no outstanding debt for DCTH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 13.95 |
ROIC/WACC0.41
WACC9.05%
2.3 Liquidity
DCTH has a Current Ratio of 10.88. This indicates that DCTH is financially healthy and has no problem in meeting its short term obligations.
DCTH has a better Current ratio (10.88) than 94.12% of its industry peers.
A Quick Ratio of 9.87 indicates that DCTH has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 9.87, DCTH belongs to the top of the industry, outperforming 93.05% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 10.88 | ||
| Quick Ratio | 9.87 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 101.96% over the past year.
Looking at the last year, DCTH shows a very strong growth in Revenue. The Revenue has grown by 491.54%.
The Revenue has been growing by 88.10% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)101.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%114.58%
Revenue 1Y (TTM)491.54%
Revenue growth 3Y118.63%
Revenue growth 5Y88.1%
Sales Q2Q%211.1%
3.2 Future
Based on estimates for the next years, DCTH will show a very strong growth in Earnings Per Share. The EPS will grow by 31.72% on average per year.
The Revenue is expected to grow by 44.98% on average over the next years. This is a very strong growth
EPS Next Y99.48%
EPS Next 2Y58.23%
EPS Next 3Y44.41%
EPS Next 5Y31.72%
Revenue Next Year164.77%
Revenue Next 2Y94.49%
Revenue Next 3Y65.81%
Revenue Next 5Y44.98%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 217.60 indicates a quite expensive valuation of DCTH.
63.10% of the companies in the same industry are more expensive than DCTH, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of DCTH to the average of the S&P500 Index (26.73), we can say DCTH is valued expensively.
A Price/Forward Earnings ratio of 22.04 indicates a rather expensive valuation of DCTH.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DCTH indicates a somewhat cheap valuation: DCTH is cheaper than 77.54% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of DCTH to the average of the S&P500 Index (34.61), we can say DCTH is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 217.6 | ||
| Fwd PE | 22.04 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DCTH indicates a somewhat cheap valuation: DCTH is cheaper than 65.78% of the companies listed in the same industry.
68.98% of the companies in the same industry are more expensive than DCTH, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 98 | ||
| EV/EBITDA | 46.06 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates DCTH does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as DCTH's earnings are expected to grow with 44.41% in the coming years.
PEG (NY)2.19
PEG (5Y)N/A
EPS Next 2Y58.23%
EPS Next 3Y44.41%
5. Dividend
5.1 Amount
DCTH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
10.88
+0.37 (+3.52%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners43.89%
Inst Owner Change3%
Ins Owners2.73%
Ins Owner Change1.29%
Market Cap378.95M
Analysts85
Price Target24.48 (125%)
Short Float %6.58%
Short Ratio3.06
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)135.29%
Min EPS beat(2)96.08%
Max EPS beat(2)174.51%
EPS beat(4)3
Avg EPS beat(4)-22.09%
Min EPS beat(4)-488.34%
Max EPS beat(4)174.51%
EPS beat(8)5
Avg EPS beat(8)-27.41%
EPS beat(12)6
Avg EPS beat(12)-22.87%
EPS beat(16)8
Avg EPS beat(16)-16.26%
Revenue beat(2)2
Avg Revenue beat(2)9.5%
Min Revenue beat(2)3.74%
Max Revenue beat(2)15.26%
Revenue beat(4)4
Avg Revenue beat(4)7.85%
Min Revenue beat(4)3.74%
Max Revenue beat(4)15.26%
Revenue beat(8)6
Avg Revenue beat(8)9.82%
Revenue beat(12)7
Avg Revenue beat(12)1.26%
Revenue beat(16)11
Avg Revenue beat(16)26.75%
PT rev (1m)0%
PT rev (3m)6.67%
EPS NQ rev (1m)7.16%
EPS NQ rev (3m)1397.01%
EPS NY rev (1m)0%
EPS NY rev (3m)-107.35%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)18.7%
Revenue NY rev (1m)-0.62%
Revenue NY rev (3m)13.85%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 217.6 | ||
| Fwd PE | 22.04 | ||
| P/S | 5.4 | ||
| P/FCF | 98 | ||
| P/OCF | 78.13 | ||
| P/B | 3.61 | ||
| P/tB | 3.61 | ||
| EV/EBITDA | 46.06 |
EPS(TTM)0.05
EY0.46%
EPS(NY)0.49
Fwd EY4.54%
FCF(TTM)0.11
FCFY1.02%
OCF(TTM)0.14
OCFY1.28%
SpS2.02
BVpS3.01
TBVpS3.01
PEG (NY)2.19
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.91% | ||
| ROE | 2.13% | ||
| ROCE | 4.71% | ||
| ROIC | 3.72% | ||
| ROICexc | 15.57% | ||
| ROICexgc | 15.57% | ||
| OM | 7.14% | ||
| PM (TTM) | 3.18% | ||
| GM | 85.86% | ||
| FCFM | 5.51% |
ROA(3y)-120.78%
ROA(5y)-101.94%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.01%
GM growth 5Y8.9%
F-Score8
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 592.17% | ||
| Cap/Sales | 1.4% | ||
| Interest Coverage | 5.82 | ||
| Cash Conversion | 93.67% | ||
| Profit Quality | 173.25% | ||
| Current Ratio | 10.88 | ||
| Quick Ratio | 9.87 | ||
| Altman-Z | 13.95 |
F-Score8
WACC9.05%
ROIC/WACC0.41
Cap/Depr(3y)208.01%
Cap/Depr(5y)235.23%
Cap/Sales(3y)4.01%
Cap/Sales(5y)12.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)101.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%114.58%
EPS Next Y99.48%
EPS Next 2Y58.23%
EPS Next 3Y44.41%
EPS Next 5Y31.72%
Revenue 1Y (TTM)491.54%
Revenue growth 3Y118.63%
Revenue growth 5Y88.1%
Sales Q2Q%211.1%
Revenue Next Year164.77%
Revenue Next 2Y94.49%
Revenue Next 3Y65.81%
Revenue Next 5Y44.98%
EBIT growth 1Y113.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year248.16%
EBIT Next 3Y84.35%
EBIT Next 5YN/A
FCF growth 1Y114.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y118.34%
OCF growth 3YN/A
OCF growth 5YN/A